Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment as prevention news

Show

From To
Vietnam Suggests Increasing HIV/AIDS Prevention Efficiency

The deputy prime minister stressed the importance of people with HIV having access to antiretroviral therapy and methadone.

Published
09 June 2011
From
Bernama
We can end the AIDS epidemic (sign on statement)

For the first time in the 30 years of the AIDS epidemic, there is now conclusive evidence showing that earlier initiation of highly active combination antiretroviral therapy (ART) at 350-550 CD4 cells/mm3 is a highly powerful tool for preventing transmission to sexual partners and has clinical benefit for HIV-positive people.

Published
08 June 2011
From
AVAC
Treatment as Prevention: Protecting patient autonomy

The recent demonstration that antiretroviral treatment can prevent transmission of HIV among serodiscordant heterosexual couples is great news.  However, when the person offered treatment has not yet been shown to personally benefit from it, an ethical issue needs to be addressed.  This is because it has yet to be reliably shown that for people with greater than 350 CD4 lymphocytes, starting treatment immediately rather than deferring it confers a net benefit; indeed, it may even prove to be harmful.  

Published
07 June 2011
From
Poz
HPTN 052: An update

Mike Cohen, principal investigator of the remarkable clinical trial that demonstrated “biological and clinical plausibility” that antiretroviral therapy (ART) offers prevention as well as treatment benefits, offered an update to a packed crowd at the annual meeting of the HIV Prevention Trials Network (HPTN).

Published
06 June 2011
From
Science Speaks
Israeli study may point to the future of the HIV epidemic in men who have sex with men

Over the past decade across high-income countries an unexpected and disturbing trend has emerged—an increase in syphilis and HIV infections among men who have sex with men (MSM). Now researchers in Israel have found similar trends in HIV in that country. Furthermore, researchers there have found that about 30% of MSM newly infected with HIV have strains that are resistant to some anti-HIV therapies.

Published
31 May 2011
From
CATIE
New HIV guidelines needed for British Columbia prosecutors

Significant risk of transmission should be key: lawyer

Published
26 May 2011
From
Xtra
Drugs Stop AIDS. Take Your Medicine.

Do the results of the recent `treatment as prevention` trial shift the balance in the debate over the rights of the patient and the goals of wider public health?

Published
23 May 2011
From
New York Times
Equal Access to HIV Treatment Could Finally Slow the US Black Epidemic

Might black Americans benefit disproportionately from the more aggressive antiretroviral therapy suggested by the HPTN 052?

Published
19 May 2011
From
Color Lines
Three Reasons That Big HIV Study May Be Less Important Than It Seems

I’m not sure that HPTN 052 is going to have the impact that you’d expect reading the breathless coverage. Here are the reasons for my skepticism.

Published
17 May 2011
From
Forbes
ARVs as prevention must move quickly "from science to action"

A landmark study showing major reductions in HIV transmission among discordant couples due to early treatment may fail to have a significant impact on HIV prevention unless governments and donors are willing to turn the science into action, HIV advocates say.

Published
13 May 2011
From
IRIN Plus News
← First12Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.